nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—Nasal ulcer—Capecitabine—esophageal cancer	0.0338	0.078	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Raltitrexed—Methotrexate—esophageal cancer	0.022	1	CbGdCrCtD
Fluticasone Propionate—Amcinonide—ANXA1—esophageal cancer	0.0107	0.395	CrCbGaD
Fluticasone Propionate—Telangiectasia—Methotrexate—esophageal cancer	0.0101	0.0232	CcSEcCtD
Fluticasone Propionate—Scab—Capecitabine—esophageal cancer	0.01	0.0231	CcSEcCtD
Fluticasone Propionate—Lower respiratory tract infection—Capecitabine—esophageal cancer	0.00934	0.0215	CcSEcCtD
Fluticasone Propionate—Bronchial hyperreactivity—Methotrexate—esophageal cancer	0.0091	0.021	CcSEcCtD
Fluticasone Propionate—Chronic obstructive pulmonary disease—Methotrexate—esophageal cancer	0.00831	0.0191	CcSEcCtD
Fluticasone Propionate—Hoarseness—Capecitabine—esophageal cancer	0.00725	0.0167	CcSEcCtD
Fluticasone Propionate—PLA2G4A—bronchus—esophageal cancer	0.00586	0.0675	CbGeAlD
Fluticasone Propionate—Sneezing—Capecitabine—esophageal cancer	0.00576	0.0133	CcSEcCtD
Fluticasone Propionate—PLA2G4A—smooth muscle tissue—esophageal cancer	0.00573	0.066	CbGeAlD
Fluticasone Propionate—Leukoderma—Methotrexate—esophageal cancer	0.00559	0.0129	CcSEcCtD
Fluticasone Propionate—Rhinorrhoea—Cisplatin—esophageal cancer	0.00534	0.0123	CcSEcCtD
Fluticasone Propionate—Ageusia—Cisplatin—esophageal cancer	0.00534	0.0123	CcSEcCtD
Fluticasone Propionate—PLA2G4A—trachea—esophageal cancer	0.00526	0.0606	CbGeAlD
Fluticasone Propionate—Infection—Carboplatin—esophageal cancer	0.00523	0.0121	CcSEcCtD
Fluticasone Propionate—Oral candidiasis—Capecitabine—esophageal cancer	0.00502	0.0116	CcSEcCtD
Fluticasone Propionate—Supraventricular tachycardia—Capecitabine—esophageal cancer	0.00487	0.0112	CcSEcCtD
Fluticasone Propionate—NR3C2—bronchus—esophageal cancer	0.00477	0.0549	CbGeAlD
Fluticasone Propionate—NR3C2—smooth muscle tissue—esophageal cancer	0.00466	0.0537	CbGeAlD
Fluticasone Propionate—Pain—Carboplatin—esophageal cancer	0.0045	0.0104	CcSEcCtD
Fluticasone Propionate—PGR—epithelium—esophageal cancer	0.0045	0.0518	CbGeAlD
Fluticasone Propionate—Blister—Capecitabine—esophageal cancer	0.00443	0.0102	CcSEcCtD
Fluticasone Propionate—Throat sore—Capecitabine—esophageal cancer	0.00443	0.0102	CcSEcCtD
Fluticasone Propionate—Oropharyngeal discomfort—Capecitabine—esophageal cancer	0.00439	0.0101	CcSEcCtD
Fluticasone Propionate—PGR—smooth muscle tissue—esophageal cancer	0.00433	0.0499	CbGeAlD
Fluticasone Propionate—NR3C2—trachea—esophageal cancer	0.00428	0.0493	CbGeAlD
Fluticasone Propionate—Osteoporosis—Methotrexate—esophageal cancer	0.00424	0.00976	CcSEcCtD
Fluticasone Propionate—Wheezing—Cisplatin—esophageal cancer	0.0042	0.00968	CcSEcCtD
Fluticasone Propionate—Rash erythematous—Capecitabine—esophageal cancer	0.00417	0.0096	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Carboplatin—esophageal cancer	0.00416	0.00959	CcSEcCtD
Fluticasone Propionate—Fracture—Methotrexate—esophageal cancer	0.00409	0.00942	CcSEcCtD
Fluticasone Propionate—Multiple fractures—Methotrexate—esophageal cancer	0.00409	0.00942	CcSEcCtD
Fluticasone Propionate—Rhinorrhoea—Capecitabine—esophageal cancer	0.00394	0.00907	CcSEcCtD
Fluticasone Propionate—Ageusia—Capecitabine—esophageal cancer	0.00394	0.00907	CcSEcCtD
Fluticasone Propionate—Dysphonia—Capecitabine—esophageal cancer	0.00388	0.00894	CcSEcCtD
Fluticasone Propionate—NR3C1—neck—esophageal cancer	0.00381	0.0439	CbGeAlD
Fluticasone Propionate—Extrasystoles—Capecitabine—esophageal cancer	0.00379	0.00874	CcSEcCtD
Fluticasone Propionate—PLA2G4A—lung—esophageal cancer	0.00378	0.0435	CbGeAlD
Fluticasone Propionate—Psoriasis—Methotrexate—esophageal cancer	0.00378	0.00871	CcSEcCtD
Fluticasone Propionate—Folliculitis—Methotrexate—esophageal cancer	0.00378	0.00871	CcSEcCtD
Fluticasone Propionate—SERPINA6—lung—esophageal cancer	0.00377	0.0434	CbGeAlD
Fluticasone Propionate—Eye irritation—Capecitabine—esophageal cancer	0.00374	0.00861	CcSEcCtD
Fluticasone Propionate—NR3C2—digestive system—esophageal cancer	0.00368	0.0424	CbGeAlD
Fluticasone Propionate—Contusion—Capecitabine—esophageal cancer	0.00366	0.00843	CcSEcCtD
Fluticasone Propionate—Oropharyngeal pain—Capecitabine—esophageal cancer	0.00351	0.00808	CcSEcCtD
Fluticasone Propionate—Lacrimation increased—Capecitabine—esophageal cancer	0.00346	0.00798	CcSEcCtD
Fluticasone Propionate—Herpes simplex—Capecitabine—esophageal cancer	0.00346	0.00798	CcSEcCtD
Fluticasone Propionate—Nasal congestion—Cisplatin—esophageal cancer	0.00345	0.00795	CcSEcCtD
Fluticasone Propionate—Dexamethasone—ANXA1—esophageal cancer	0.00337	0.124	CrCbGaD
Fluticasone Propionate—Cataract—Capecitabine—esophageal cancer	0.00335	0.00772	CcSEcCtD
Fluticasone Propionate—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00325	0.00748	CcSEcCtD
Fluticasone Propionate—Influenza like illness—Capecitabine—esophageal cancer	0.0031	0.00714	CcSEcCtD
Fluticasone Propionate—NR3C2—lung—esophageal cancer	0.00307	0.0354	CbGeAlD
Fluticasone Propionate—Candida infection—Capecitabine—esophageal cancer	0.00305	0.00702	CcSEcCtD
Fluticasone Propionate—Face oedema—Cisplatin—esophageal cancer	0.00303	0.00699	CcSEcCtD
Fluticasone Propionate—Irritability—Cisplatin—esophageal cancer	0.003	0.00691	CcSEcCtD
Fluticasone Propionate—PGR—lung—esophageal cancer	0.00286	0.0329	CbGeAlD
Fluticasone Propionate—Cramp muscle—Cisplatin—esophageal cancer	0.00283	0.00652	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Cisplatin—esophageal cancer	0.00281	0.00647	CcSEcCtD
Fluticasone Propionate—Sleep disorder—Capecitabine—esophageal cancer	0.00268	0.00616	CcSEcCtD
Fluticasone Propionate—Diabetes mellitus—Capecitabine—esophageal cancer	0.00266	0.00613	CcSEcCtD
Fluticasone Propionate—Abdominal discomfort—Cisplatin—esophageal cancer	0.0026	0.006	CcSEcCtD
Fluticasone Propionate—NR3C1—epithelium—esophageal cancer	0.0026	0.0299	CbGeAlD
Fluticasone Propionate—PLA2G4A—lymph node—esophageal cancer	0.00259	0.0298	CbGeAlD
Fluticasone Propionate—Herpes simplex—Methotrexate—esophageal cancer	0.00258	0.00594	CcSEcCtD
Fluticasone Propionate—NR3C1—bronchus—esophageal cancer	0.00256	0.0294	CbGeAlD
Fluticasone Propionate—NR3C1—smooth muscle tissue—esophageal cancer	0.0025	0.0288	CbGeAlD
Fluticasone Propionate—Atrial fibrillation—Capecitabine—esophageal cancer	0.00244	0.00563	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Capecitabine—esophageal cancer	0.00242	0.00558	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Cisplatin—esophageal cancer	0.00235	0.00542	CcSEcCtD
Fluticasone Propionate—NR3C1—trachea—esophageal cancer	0.0023	0.0264	CbGeAlD
Fluticasone Propionate—Face oedema—Capecitabine—esophageal cancer	0.00224	0.00515	CcSEcCtD
Fluticasone Propionate—Irritability—Capecitabine—esophageal cancer	0.00221	0.00509	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Cisplatin—esophageal cancer	0.00214	0.00492	CcSEcCtD
Fluticasone Propionate—NR3C2—lymph node—esophageal cancer	0.0021	0.0242	CbGeAlD
Fluticasone Propionate—Nasopharyngitis—Capecitabine—esophageal cancer	0.00207	0.00477	CcSEcCtD
Fluticasone Propionate—Eye disorder—Cisplatin—esophageal cancer	0.00203	0.00468	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Cisplatin—esophageal cancer	0.00202	0.00465	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Capecitabine—esophageal cancer	0.00201	0.00464	CcSEcCtD
Fluticasone Propionate—Asthma—Capecitabine—esophageal cancer	0.002	0.00461	CcSEcCtD
Fluticasone Propionate—CYP3A5—digestive system—esophageal cancer	0.00199	0.0229	CbGeAlD
Fluticasone Propionate—Diabetes mellitus—Methotrexate—esophageal cancer	0.00198	0.00457	CcSEcCtD
Fluticasone Propionate—NR3C1—digestive system—esophageal cancer	0.00197	0.0227	CbGeAlD
Fluticasone Propionate—Bronchospasm—Capecitabine—esophageal cancer	0.00197	0.00454	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Cisplatin—esophageal cancer	0.00196	0.00452	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Cisplatin—esophageal cancer	0.00196	0.00451	CcSEcCtD
Fluticasone Propionate—PGR—lymph node—esophageal cancer	0.00195	0.0225	CbGeAlD
Fluticasone Propionate—Arrhythmia—Cisplatin—esophageal cancer	0.00194	0.00447	CcSEcCtD
Fluticasone Propionate—Bronchitis—Capecitabine—esophageal cancer	0.00192	0.00444	CcSEcCtD
Fluticasone Propionate—Abdominal discomfort—Capecitabine—esophageal cancer	0.00192	0.00442	CcSEcCtD
Fluticasone Propionate—Erythema—Cisplatin—esophageal cancer	0.00189	0.00436	CcSEcCtD
Fluticasone Propionate—Malnutrition—Cisplatin—esophageal cancer	0.00189	0.00436	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00186	0.00429	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Cisplatin—esophageal cancer	0.00182	0.00419	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Capecitabine—esophageal cancer	0.00181	0.00416	CcSEcCtD
Fluticasone Propionate—Pneumonia—Capecitabine—esophageal cancer	0.00179	0.00414	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Capecitabine—esophageal cancer	0.00178	0.00411	CcSEcCtD
Fluticasone Propionate—Infestation—Capecitabine—esophageal cancer	0.00178	0.00411	CcSEcCtD
Fluticasone Propionate—Vision blurred—Cisplatin—esophageal cancer	0.00178	0.00411	CcSEcCtD
Fluticasone Propionate—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00178	0.0041	CcSEcCtD
Fluticasone Propionate—Tremor—Cisplatin—esophageal cancer	0.00177	0.00408	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Cisplatin—esophageal cancer	0.00176	0.00404	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Capecitabine—esophageal cancer	0.00173	0.004	CcSEcCtD
Fluticasone Propionate—Malaise—Cisplatin—esophageal cancer	0.00171	0.00393	CcSEcCtD
Fluticasone Propionate—Betamethasone—CYP19A1—esophageal cancer	0.00169	0.0623	CrCbGaD
Fluticasone Propionate—Epistaxis—Capecitabine—esophageal cancer	0.00168	0.00388	CcSEcCtD
Fluticasone Propionate—CYP3A5—lung—esophageal cancer	0.00166	0.0191	CbGeAlD
Fluticasone Propionate—NR3C1—lung—esophageal cancer	0.00165	0.019	CbGeAlD
Fluticasone Propionate—Irritability—Methotrexate—esophageal cancer	0.00165	0.00379	CcSEcCtD
Fluticasone Propionate—Anxiety—Cisplatin—esophageal cancer	0.00161	0.0037	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.0016	0.00369	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Capecitabine—esophageal cancer	0.00159	0.00367	CcSEcCtD
Fluticasone Propionate—Discomfort—Cisplatin—esophageal cancer	0.00159	0.00367	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Capecitabine—esophageal cancer	0.00159	0.00366	CcSEcCtD
Fluticasone Propionate—Dexamethasone—NOS2—esophageal cancer	0.00158	0.0581	CrCbGaD
Fluticasone Propionate—Connective tissue disorder—Capecitabine—esophageal cancer	0.00157	0.00363	CcSEcCtD
Fluticasone Propionate—Oedema—Cisplatin—esophageal cancer	0.00154	0.00356	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Cisplatin—esophageal cancer	0.00154	0.00356	CcSEcCtD
Fluticasone Propionate—Infection—Cisplatin—esophageal cancer	0.00153	0.00353	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Cisplatin—esophageal cancer	0.00151	0.00349	CcSEcCtD
Fluticasone Propionate—Tachycardia—Cisplatin—esophageal cancer	0.00151	0.00347	CcSEcCtD
Fluticasone Propionate—Skin disorder—Cisplatin—esophageal cancer	0.0015	0.00346	CcSEcCtD
Fluticasone Propionate—Eye disorder—Capecitabine—esophageal cancer	0.0015	0.00345	CcSEcCtD
Fluticasone Propionate—CYP3A4—digestive system—esophageal cancer	0.00149	0.0172	CbGeAlD
Fluticasone Propionate—Asthma—Methotrexate—esophageal cancer	0.00149	0.00343	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Capecitabine—esophageal cancer	0.00149	0.00343	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Capecitabine—esophageal cancer	0.00145	0.00333	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Capecitabine—esophageal cancer	0.00144	0.00333	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Capecitabine—esophageal cancer	0.00143	0.0033	CcSEcCtD
Fluticasone Propionate—Abdominal discomfort—Methotrexate—esophageal cancer	0.00143	0.00329	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00141	0.00324	CcSEcCtD
Fluticasone Propionate—Mental disorder—Capecitabine—esophageal cancer	0.0014	0.00323	CcSEcCtD
Fluticasone Propionate—Erythema—Capecitabine—esophageal cancer	0.00139	0.00321	CcSEcCtD
Fluticasone Propionate—Malnutrition—Capecitabine—esophageal cancer	0.00139	0.00321	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00138	0.00319	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Cisplatin—esophageal cancer	0.00138	0.00317	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP1B1—esophageal cancer	0.00134	0.0494	CrCbGaD
Fluticasone Propionate—Muscle spasms—Capecitabine—esophageal cancer	0.00134	0.00309	CcSEcCtD
Fluticasone Propionate—Pneumonia—Methotrexate—esophageal cancer	0.00134	0.00308	CcSEcCtD
Fluticasone Propionate—Infestation—Methotrexate—esophageal cancer	0.00133	0.00306	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Methotrexate—esophageal cancer	0.00133	0.00306	CcSEcCtD
Fluticasone Propionate—Pain—Cisplatin—esophageal cancer	0.00132	0.00304	CcSEcCtD
Fluticasone Propionate—Vision blurred—Capecitabine—esophageal cancer	0.00131	0.00303	CcSEcCtD
Fluticasone Propionate—Tremor—Capecitabine—esophageal cancer	0.00131	0.00301	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Capecitabine—esophageal cancer	0.00129	0.00298	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Methotrexate—esophageal cancer	0.00129	0.00298	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Cisplatin—esophageal cancer	0.00127	0.00293	CcSEcCtD
Fluticasone Propionate—Malaise—Capecitabine—esophageal cancer	0.00126	0.0029	CcSEcCtD
Fluticasone Propionate—Epistaxis—Methotrexate—esophageal cancer	0.00125	0.00289	CcSEcCtD
Fluticasone Propionate—Palpitations—Capecitabine—esophageal cancer	0.00123	0.00284	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Cisplatin—esophageal cancer	0.00122	0.00281	CcSEcCtD
Fluticasone Propionate—Cough—Capecitabine—esophageal cancer	0.00122	0.0028	CcSEcCtD
Fluticasone Propionate—Hypertension—Capecitabine—esophageal cancer	0.0012	0.00277	CcSEcCtD
Fluticasone Propionate—Fluticasone furoate—ABCB1—esophageal cancer	0.0012	0.0442	CrCbGaD
Fluticasone Propionate—Arthralgia—Capecitabine—esophageal cancer	0.00119	0.00274	CcSEcCtD
Fluticasone Propionate—Chest pain—Capecitabine—esophageal cancer	0.00119	0.00274	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Methotrexate—esophageal cancer	0.00118	0.00273	CcSEcCtD
Fluticasone Propionate—Anxiety—Capecitabine—esophageal cancer	0.00118	0.00273	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00118	0.00272	CcSEcCtD
Fluticasone Propionate—Discomfort—Capecitabine—esophageal cancer	0.00117	0.0027	CcSEcCtD
Fluticasone Propionate—Dry mouth—Capecitabine—esophageal cancer	0.00116	0.00268	CcSEcCtD
Fluticasone Propionate—Oedema—Capecitabine—esophageal cancer	0.00114	0.00262	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Cisplatin—esophageal cancer	0.00114	0.00262	CcSEcCtD
Fluticasone Propionate—Infection—Capecitabine—esophageal cancer	0.00113	0.00261	CcSEcCtD
Fluticasone Propionate—NR3C1—lymph node—esophageal cancer	0.00113	0.013	CbGeAlD
Fluticasone Propionate—Nervous system disorder—Capecitabine—esophageal cancer	0.00112	0.00257	CcSEcCtD
Fluticasone Propionate—Eye disorder—Methotrexate—esophageal cancer	0.00111	0.00257	CcSEcCtD
Fluticasone Propionate—Tachycardia—Capecitabine—esophageal cancer	0.00111	0.00256	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Methotrexate—esophageal cancer	0.00111	0.00255	CcSEcCtD
Fluticasone Propionate—Skin disorder—Capecitabine—esophageal cancer	0.00111	0.00255	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Methotrexate—esophageal cancer	0.00108	0.00248	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Methotrexate—esophageal cancer	0.00107	0.00248	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Cisplatin—esophageal cancer	0.00106	0.00243	CcSEcCtD
Fluticasone Propionate—Dexamethasone—ABCC2—esophageal cancer	0.00105	0.0385	CrCbGaD
Fluticasone Propionate—Mental disorder—Methotrexate—esophageal cancer	0.00104	0.00241	CcSEcCtD
Fluticasone Propionate—Erythema—Methotrexate—esophageal cancer	0.00104	0.00239	CcSEcCtD
Fluticasone Propionate—Malnutrition—Methotrexate—esophageal cancer	0.00104	0.00239	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00104	0.00239	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP2A6—esophageal cancer	0.00103	0.0381	CrCbGaD
Fluticasone Propionate—Dyspnoea—Capecitabine—esophageal cancer	0.00101	0.00234	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP19A1—esophageal cancer	0.000984	0.0362	CrCbGaD
Fluticasone Propionate—Vomiting—Cisplatin—esophageal cancer	0.000982	0.00226	CcSEcCtD
Fluticasone Propionate—Vision blurred—Methotrexate—esophageal cancer	0.000978	0.00225	CcSEcCtD
Fluticasone Propionate—Rash—Cisplatin—esophageal cancer	0.000974	0.00224	CcSEcCtD
Fluticasone Propionate—Pain—Capecitabine—esophageal cancer	0.000973	0.00224	CcSEcCtD
Fluticasone Propionate—Dermatitis—Cisplatin—esophageal cancer	0.000973	0.00224	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Methotrexate—esophageal cancer	0.000963	0.00222	CcSEcCtD
Fluticasone Propionate—Methylprednisolone—ABCB1—esophageal cancer	0.000958	0.0353	CrCbGaD
Fluticasone Propionate—Triamcinolone—PTGS2—esophageal cancer	0.00095	0.035	CrCbGaD
Fluticasone Propionate—Feeling abnormal—Capecitabine—esophageal cancer	0.000938	0.00216	CcSEcCtD
Fluticasone Propionate—Malaise—Methotrexate—esophageal cancer	0.000936	0.00216	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000931	0.00214	CcSEcCtD
Fluticasone Propionate—Nausea—Cisplatin—esophageal cancer	0.000917	0.00211	CcSEcCtD
Fluticasone Propionate—Cough—Methotrexate—esophageal cancer	0.000906	0.00209	CcSEcCtD
Fluticasone Propionate—Urticaria—Capecitabine—esophageal cancer	0.000904	0.00208	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Capecitabine—esophageal cancer	0.0009	0.00207	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Capecitabine—esophageal cancer	0.0009	0.00207	CcSEcCtD
Fluticasone Propionate—Arthralgia—Methotrexate—esophageal cancer	0.000884	0.00204	CcSEcCtD
Fluticasone Propionate—Chest pain—Methotrexate—esophageal cancer	0.000884	0.00204	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000878	0.00202	CcSEcCtD
Fluticasone Propionate—Discomfort—Methotrexate—esophageal cancer	0.000873	0.00201	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Methotrexate—esophageal cancer	0.000847	0.00195	CcSEcCtD
Fluticasone Propionate—Infection—Methotrexate—esophageal cancer	0.000842	0.00194	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Capecitabine—esophageal cancer	0.000839	0.00193	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Methotrexate—esophageal cancer	0.000831	0.00191	CcSEcCtD
Fluticasone Propionate—Skin disorder—Methotrexate—esophageal cancer	0.000823	0.0019	CcSEcCtD
Fluticasone Propionate—Pruritus—Capecitabine—esophageal cancer	0.000805	0.00186	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Capecitabine—esophageal cancer	0.000779	0.00179	CcSEcCtD
Fluticasone Propionate—Betamethasone—PTGS2—esophageal cancer	0.000778	0.0287	CrCbGaD
Fluticasone Propionate—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000772	0.00178	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Methotrexate—esophageal cancer	0.000755	0.00174	CcSEcCtD
Fluticasone Propionate—Dizziness—Capecitabine—esophageal cancer	0.000753	0.00173	CcSEcCtD
Fluticasone Propionate—Pain—Methotrexate—esophageal cancer	0.000725	0.00167	CcSEcCtD
Fluticasone Propionate—Vomiting—Capecitabine—esophageal cancer	0.000724	0.00167	CcSEcCtD
Fluticasone Propionate—Rash—Capecitabine—esophageal cancer	0.000718	0.00165	CcSEcCtD
Fluticasone Propionate—Dermatitis—Capecitabine—esophageal cancer	0.000717	0.00165	CcSEcCtD
Fluticasone Propionate—Headache—Capecitabine—esophageal cancer	0.000713	0.00164	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Methotrexate—esophageal cancer	0.000698	0.00161	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000693	0.0016	CcSEcCtD
Fluticasone Propionate—Nausea—Capecitabine—esophageal cancer	0.000676	0.00156	CcSEcCtD
Fluticasone Propionate—Urticaria—Methotrexate—esophageal cancer	0.000673	0.00155	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Methotrexate—esophageal cancer	0.00067	0.00154	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Methotrexate—esophageal cancer	0.00067	0.00154	CcSEcCtD
Fluticasone Propionate—Betamethasone—ABCB1—esophageal cancer	0.000662	0.0244	CrCbGaD
Fluticasone Propionate—Hypersensitivity—Methotrexate—esophageal cancer	0.000624	0.00144	CcSEcCtD
Fluticasone Propionate—Pruritus—Methotrexate—esophageal cancer	0.000599	0.00138	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Methotrexate—esophageal cancer	0.00058	0.00134	CcSEcCtD
Fluticasone Propionate—Dizziness—Methotrexate—esophageal cancer	0.00056	0.00129	CcSEcCtD
Fluticasone Propionate—Vomiting—Methotrexate—esophageal cancer	0.000539	0.00124	CcSEcCtD
Fluticasone Propionate—Rash—Methotrexate—esophageal cancer	0.000534	0.00123	CcSEcCtD
Fluticasone Propionate—Dermatitis—Methotrexate—esophageal cancer	0.000534	0.00123	CcSEcCtD
Fluticasone Propionate—Headache—Methotrexate—esophageal cancer	0.000531	0.00122	CcSEcCtD
Fluticasone Propionate—Nausea—Methotrexate—esophageal cancer	0.000503	0.00116	CcSEcCtD
Fluticasone Propionate—Dexamethasone—PTGS2—esophageal cancer	0.000453	0.0167	CrCbGaD
Fluticasone Propionate—Dexamethasone—ABCB1—esophageal cancer	0.000385	0.0142	CrCbGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—WWOX—esophageal cancer	0.000293	0.000681	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PFN1—esophageal cancer	0.000288	0.000669	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ADH1B—esophageal cancer	0.000286	0.000664	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000283	0.000657	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FKBP1A—esophageal cancer	0.000279	0.000648	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—PSME2—esophageal cancer	0.000278	0.000647	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—PSME1—esophageal cancer	0.000278	0.000647	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000276	0.000641	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000274	0.000638	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—TYMP—esophageal cancer	0.000273	0.000635	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—WIF1—esophageal cancer	0.000272	0.000633	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.000268	0.000623	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CXCL2—esophageal cancer	0.000268	0.000623	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—MYC—esophageal cancer	0.000267	0.000622	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CA1—esophageal cancer	0.000267	0.000621	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—SLC10A2—esophageal cancer	0.000267	0.000621	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP26A1—esophageal cancer	0.000266	0.000617	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—NOTCH3—esophageal cancer	0.000262	0.00061	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000262	0.000609	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.000262	0.000609	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000259	0.000602	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ALOX15—esophageal cancer	0.000259	0.000602	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ELMO1—esophageal cancer	0.000259	0.000601	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000256	0.000595	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKAP13—esophageal cancer	0.000253	0.000588	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CSNK1A1—esophageal cancer	0.000251	0.000584	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—ANXA1—esophageal cancer	0.000249	0.000579	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—TPI1—esophageal cancer	0.000247	0.000574	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GSTO1—esophageal cancer	0.000247	0.000574	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000246	0.000571	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CA2—esophageal cancer	0.000244	0.000568	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—SST—esophageal cancer	0.000242	0.000563	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—NR1I2—esophageal cancer	0.000242	0.000562	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—NOTCH1—esophageal cancer	0.000239	0.000556	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000237	0.000552	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ALDOB—esophageal cancer	0.000237	0.00055	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—GHRL—esophageal cancer	0.000236	0.000549	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—NOTCH2—esophageal cancer	0.000235	0.000547	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PFN1—esophageal cancer	0.000235	0.000547	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000233	0.000542	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PDE4D—esophageal cancer	0.000231	0.000537	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—NOS2—esophageal cancer	0.000231	0.000536	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GAPDH—esophageal cancer	0.000228	0.00053	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.000227	0.000529	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ADH7—esophageal cancer	0.000227	0.000528	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PLCE1—esophageal cancer	0.000227	0.000528	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—BLVRB—esophageal cancer	0.000227	0.000528	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SLC52A3—esophageal cancer	0.000227	0.000528	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CRABP1—esophageal cancer	0.000226	0.000525	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.00022	0.000511	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GNG7—esophageal cancer	0.00022	0.000511	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—CREBBP—esophageal cancer	0.000217	0.000504	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GNG7—esophageal cancer	0.000215	0.000499	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ELMO1—esophageal cancer	0.000211	0.000491	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000209	0.000486	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—HIST1H2BM—esophageal cancer	0.000207	0.000482	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—CREBBP—esophageal cancer	0.000207	0.000481	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKAP13—esophageal cancer	0.000206	0.00048	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000206	0.000479	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—XIAP—esophageal cancer	0.000206	0.000479	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	0.000202	0.00047	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ALDH2—esophageal cancer	0.000201	0.000468	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ADH1B—esophageal cancer	0.000199	0.000463	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—SMAD4—esophageal cancer	0.000198	0.00046	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000196	0.000457	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CTNNA1—esophageal cancer	0.000195	0.000453	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000194	0.00045	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CXCL2—esophageal cancer	0.000194	0.00045	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SLC10A2—esophageal cancer	0.000193	0.000449	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CA1—esophageal cancer	0.000193	0.000449	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GSTT1—esophageal cancer	0.000191	0.000445	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.00019	0.000443	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—TYMP—esophageal cancer	0.00019	0.000442	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP2A6—esophageal cancer	0.000189	0.00044	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PDE4D—esophageal cancer	0.000189	0.000439	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000188	0.000438	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—NOS3—esophageal cancer	0.000185	0.000431	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP26A1—esophageal cancer	0.000185	0.00043	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PSME2—esophageal cancer	0.000181	0.000421	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PSME1—esophageal cancer	0.000181	0.000421	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ALOX15—esophageal cancer	0.00018	0.000419	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ANXA1—esophageal cancer	0.00018	0.000419	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GNG7—esophageal cancer	0.00018	0.000418	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ENO1—esophageal cancer	0.000179	0.000417	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS1—esophageal cancer	0.000179	0.000417	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PSME2—esophageal cancer	0.000177	0.000411	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PSME1—esophageal cancer	0.000177	0.000411	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CA2—esophageal cancer	0.000176	0.00041	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SST—esophageal cancer	0.000175	0.000407	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000175	0.000407	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—TPI1—esophageal cancer	0.000172	0.0004	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTO1—esophageal cancer	0.000172	0.0004	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOTCH3—esophageal cancer	0.000171	0.000397	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GHRL—esophageal cancer	0.000171	0.000397	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—XIAP—esophageal cancer	0.000168	0.000391	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FBXW7—esophageal cancer	0.000168	0.00039	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ALDOB—esophageal cancer	0.000165	0.000383	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ADH7—esophageal cancer	0.000164	0.000382	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PLCE1—esophageal cancer	0.000164	0.000382	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—MYC—esophageal cancer	0.000163	0.000379	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PSME2—esophageal cancer	0.000161	0.000374	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PSME1—esophageal cancer	0.000161	0.000374	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CTNNA1—esophageal cancer	0.000159	0.00037	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GAPDH—esophageal cancer	0.000159	0.000369	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000159	0.000369	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CXCL2—esophageal cancer	0.000158	0.000368	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CRABP1—esophageal cancer	0.000157	0.000366	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000154	0.000359	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOTCH2—esophageal cancer	0.000153	0.000356	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP1B1—esophageal cancer	0.000153	0.000355	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—NOTCH3—esophageal cancer	0.000152	0.000353	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GNG7—esophageal cancer	0.00015	0.000348	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PSME2—esophageal cancer	0.000148	0.000344	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PSME1—esophageal cancer	0.000148	0.000344	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ANXA1—esophageal cancer	0.000147	0.000342	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—NOTCH1—esophageal cancer	0.000146	0.000339	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ADH1B—esophageal cancer	0.000144	0.000335	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP19A1—esophageal cancer	0.000143	0.000333	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SST—esophageal cancer	0.000143	0.000333	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—EP300—esophageal cancer	0.000141	0.000328	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ALDH2—esophageal cancer	0.00014	0.000326	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GHRL—esophageal cancer	0.000139	0.000324	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOTCH3—esophageal cancer	0.000139	0.000324	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—TYMP—esophageal cancer	0.000137	0.00032	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FBXW7—esophageal cancer	0.000137	0.000319	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—NOTCH2—esophageal cancer	0.000136	0.000316	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TGFBR2—esophageal cancer	0.000136	0.000316	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP26A1—esophageal cancer	0.000134	0.000311	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTT1—esophageal cancer	0.000133	0.00031	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—CREBBP—esophageal cancer	0.000132	0.000307	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP2A6—esophageal cancer	0.000132	0.000307	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—HMOX1—esophageal cancer	0.000131	0.000304	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALOX15—esophageal cancer	0.00013	0.000303	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—MYC—esophageal cancer	0.000129	0.000299	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SMAD4—esophageal cancer	0.000129	0.000299	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000128	0.000298	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ABCB1—esophageal cancer	0.000126	0.000292	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOTCH2—esophageal cancer	0.000125	0.000291	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS1—esophageal cancer	0.000125	0.000291	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ENO1—esophageal cancer	0.000125	0.000291	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTO1—esophageal cancer	0.000124	0.000289	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—TPI1—esophageal cancer	0.000124	0.000289	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PSME2—esophageal cancer	0.000123	0.000286	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PSME1—esophageal cancer	0.000123	0.000286	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALDOB—esophageal cancer	0.000119	0.000277	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GAPDH—esophageal cancer	0.000115	0.000267	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—SMAD4—esophageal cancer	0.000114	0.000266	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CRABP1—esophageal cancer	0.000114	0.000264	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TGFBR2—esophageal cancer	0.000111	0.000258	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GNG7—esophageal cancer	0.000108	0.000252	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP1B1—esophageal cancer	0.000106	0.000247	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000106	0.000245	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000106	0.000245	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HIF1A—esophageal cancer	0.000105	0.000245	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SMAD4—esophageal cancer	0.000105	0.000244	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—PIK3CA—esophageal cancer	0.000104	0.000243	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALDH2—esophageal cancer	0.000101	0.000236	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TP53—esophageal cancer	0.000101	0.000235	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KDR—esophageal cancer	0.000101	0.000234	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP19A1—esophageal cancer	9.99e-05	0.000232	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTT1—esophageal cancer	9.64e-05	0.000224	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP2A6—esophageal cancer	9.53e-05	0.000222	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.5e-05	0.000221	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOTCH1—esophageal cancer	9.48e-05	0.00022	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—MYC—esophageal cancer	9.41e-05	0.000219	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—HMOX1—esophageal cancer	9.12e-05	0.000212	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS1—esophageal cancer	9.03e-05	0.00021	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ENO1—esophageal cancer	9.03e-05	0.00021	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC10A2—esophageal cancer	8.97e-05	0.000209	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CA1—esophageal cancer	8.97e-05	0.000209	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PSME1—esophageal cancer	8.9e-05	0.000207	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PSME2—esophageal cancer	8.9e-05	0.000207	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ABCB1—esophageal cancer	8.75e-05	0.000204	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HIF1A—esophageal cancer	8.59e-05	0.0002	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CREBBP—esophageal cancer	8.59e-05	0.0002	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—NOTCH1—esophageal cancer	8.42e-05	0.000196	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CREBBP—esophageal cancer	8.39e-05	0.000195	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KDR—esophageal cancer	8.22e-05	0.000191	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CA2—esophageal cancer	8.21e-05	0.000191	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MYC—esophageal cancer	7.84e-05	0.000182	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOTCH1—esophageal cancer	7.74e-05	0.00018	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOS3—esophageal cancer	7.69e-05	0.000179	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP1B1—esophageal cancer	7.68e-05	0.000179	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—CREBBP—esophageal cancer	7.64e-05	0.000178	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PLCE1—esophageal cancer	7.63e-05	0.000177	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ADH7—esophageal cancer	7.63e-05	0.000177	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—NOS3—esophageal cancer	7.51e-05	0.000175	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP19A1—esophageal cancer	7.22e-05	0.000168	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ERBB2—esophageal cancer	7.19e-05	0.000167	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CREBBP—esophageal cancer	7.02e-05	0.000163	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—EGFR—esophageal cancer	6.9e-05	0.00016	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS2—esophageal cancer	6.87e-05	0.00016	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ADH1B—esophageal cancer	6.69e-05	0.000156	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—HMOX1—esophageal cancer	6.59e-05	0.000153	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—TYMP—esophageal cancer	6.39e-05	0.000149	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCND1—esophageal cancer	6.36e-05	0.000148	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ABCB1—esophageal cancer	6.33e-05	0.000147	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOS3—esophageal cancer	6.28e-05	0.000146	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP26A1—esophageal cancer	6.22e-05	0.000145	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN1A—esophageal cancer	6.15e-05	0.000143	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.06e-05	0.000141	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CA—esophageal cancer	5.99e-05	0.000139	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ERBB2—esophageal cancer	5.88e-05	0.000137	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EP300—esophageal cancer	5.85e-05	0.000136	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CREBBP—esophageal cancer	5.85e-05	0.000136	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTO1—esophageal cancer	5.78e-05	0.000134	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—TPI1—esophageal cancer	5.78e-05	0.000134	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—EP300—esophageal cancer	5.72e-05	0.000133	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALDOB—esophageal cancer	5.54e-05	0.000129	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GAPDH—esophageal cancer	5.34e-05	0.000124	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.29e-05	0.000123	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—NOS3—esophageal cancer	5.24e-05	0.000122	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCND1—esophageal cancer	5.19e-05	0.000121	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MYC—esophageal cancer	5.1e-05	0.000119	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GNG7—esophageal cancer	5.03e-05	0.000117	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN1A—esophageal cancer	5.02e-05	0.000117	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EGFR—esophageal cancer	4.99e-05	0.000116	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS2—esophageal cancer	4.79e-05	0.000111	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EP300—esophageal cancer	4.78e-05	0.000111	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALDH2—esophageal cancer	4.71e-05	0.00011	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MYC—esophageal cancer	4.53e-05	0.000105	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.48e-05	0.000104	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.43e-05	0.000103	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CA—esophageal cancer	4.33e-05	0.000101	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CA—esophageal cancer	4.23e-05	9.83e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CREBBP—esophageal cancer	4.23e-05	9.83e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.2e-05	9.77e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ENO1—esophageal cancer	4.2e-05	9.77e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TP53—esophageal cancer	4.19e-05	9.74e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MYC—esophageal cancer	4.17e-05	9.69e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PSME2—esophageal cancer	4.14e-05	9.62e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PSME1—esophageal cancer	4.14e-05	9.62e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EGFR—esophageal cancer	4.07e-05	9.47e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—EP300—esophageal cancer	3.98e-05	9.26e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NOS3—esophageal cancer	3.79e-05	8.8e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.57e-05	8.3e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CA—esophageal cancer	3.54e-05	8.22e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS2—esophageal cancer	3.46e-05	8.05e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TP53—esophageal cancer	3.42e-05	7.95e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.36e-05	7.81e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.06e-05	7.13e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CA—esophageal cancer	2.95e-05	6.85e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.94e-05	6.84e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—EP300—esophageal cancer	2.88e-05	6.7e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CA—esophageal cancer	2.13e-05	4.95e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.97e-05	4.57e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NOS3—esophageal cancer	1.76e-05	4.09e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.61e-05	3.74e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—EP300—esophageal cancer	1.34e-05	3.11e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CA—esophageal cancer	9.9e-06	2.3e-05	CbGpPWpGaD
